Letter

Co-proxamol and suicide

BMJ 2003; 327 doi: 10.1136/bmj.327.7409.287 (Published 31 July 2003)
Cite this as: BMJ 2003;327:287.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Licence needs to be changed

  1. D N Bateman, reader in clinical pharmacology (nick.bateman@luht.scot.nhs.uk),
  2. R Afshari, postgraduate fellow
  1. Scottish Poisons Information Bureau, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA

    EDITOR—We agree with Hawton et al that co-proxamol presents a major overdose hazard, their results illustrating the difficulties for licensing authorities in limiting availability of prescription medicines that are only hazardous in overdose.1

    Co-proxamol is more likely to result in death; it causes prolongation …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular